FDA Reviewers: Sanofi (France)'s Allergy Drug Can Go OTC

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Sanofi SA's allergy drug Nasacort AQ is safe enough to be used without a prescription, according to reviewers for the U.S. Food and Drug Administration. The reviewers, whose opinions were posted on the FDA's website on Monday, said the nasal spray, which currently requires a prescription, "has a favorable risk-benefit profile" for over-the-counter use. An advisory committee to the FDA is to decide on Wednesday whether to recommend making Nasacort AQ an over-the-counter product.

Help employers find you! Check out all the jobs and post your resume.

Back to news